|
|
|
|
| Symbol(s): |
SNTS |
| Date: |
13-May-13 |
| Author: |
Hunter Orr |
| Contributor: |
Alpha Street Research |
| Title: |
SNTS - Santarus Inc - Upgraded to a Buy - Company Analysis and ASR Ranking Report |
| Document Size: |
9 pages |
| Price: |
$24 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $24. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison, and our proprietary ASR Ranking indicating Buy/Sell/Hold. Santarus Inc. is a pharmaceutical company focused on acquiring, developing and commercializing proprietary products for patients treated by gastroenterologists and other physicians. The company currently markets products for the treatment of upper GI diseases and disorders and type 2 diabetes, and is developing drugs for...
| | |
|
|
